List of Figures
Figure 1: CRC Therapeutics Market, Australia, Age-Specific Incidence and Mortality Rate (per 100,000) in 2013 11
Figure 2: CRC Therapeutics, Treatment Algorithm for mCRC 25
Figure 3: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products, 2018 41
Figure 4: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for First-line Marketed Products, 2018 42
Figure 5: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Second-line Marketed Products, 2018 43
Figure 6: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Third or Fourth-line Marketed Products, 2018 43
Figure 7: CRC Therapeutics Market, Global, Pipeline, 2018 46
Figure 8: CRC Therapeutics Market, Global, Pipeline by Molecular Target, 2018 48
Figure 9: CRC Therapeutics Market, Pipeline by Molecular Target and Stage of Development, 2018 49
Figure 10: CRC Therapeutics Market, APAC, Keytruda Forecast ($m), 2020–2024 51
Figure 11: CRC Therapeutics Market, APAC, Opdivo Forecast ($m), 2023–2024 53
Figure 12: CRC Therapeutics Market, APAC, Napabucasin Forecast ($m), 2022–2024 55
Figure 13: CRC Therapeutics Market, APAC, Encorafenib plus Binimetinib Forecast ($m), 2021–2024 57
Figure 14: CRC Therapeutics Market, APAC, Fruquintinib Forecast ($m), 2018–2024 58
Figure 15: CRC Therapeutics Market, APAC, Famitinib Forecast ($m), 2021–2024 59
Figure 16: CRC Therapeutics Market, APAC, Anlotinib Forecast ($m), 2020–2024 60
Figure 17: CRC Therapeutics Market, APAC, Donafenib Forecast ($m), 2021–2024 61
Figure 18: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Pipeline Products, 2018 61
Figure 19: CRC Therapeutics Market, Competitor Matrix for CRC Marketed and Pipeline Products, 2018 63
Figure 20: CRC Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2007–2017 65
Figure 21: CRC Therapeutics, Global, Clinical Trial Failure Rates by Molecule Type (%), 2007–2017 66
Figure 22: CRC Therapeutics, Global, Clinical Trial Failure Rates by Molecular Target (%), 2007–2017 67
Figure 23: CRC Therapeutics, Global, Clinical Trial Size per Product by Molecule Type (participants), 2007–2017 68
Figure 24: CRC Therapeutics, Global, Clinical Trial Size per Product by Molecular Target (participants), 2007–2017 69
Figure 25: CRC Therapeutics, Global, Clinical Trial Size per Trial by Molecule Type (participants), 2007–2017 70
Figure 26: CRC Therapeutics, Global, Clinical Trial Size per Trial by Molecular Target (participants), 2007–2017 71
Figure 27: CRC Therapeutics, Global, Clinical Trial Duration by Molecule Type (months), 2007–2017 72
Figure 28: CRC Therapeutics, Global, Clinical Trial Duration by Molecular Target (months), 2007–2017 73
Figure 29: CRC Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 74
Figure 30: CRC Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 74
Figure 31: CRC Therapeutics Market, APAC, Treatment Patterns (‘000), 2017–2024 76
Figure 32: CRC Therapeutics Market, APAC, Market Size ($bn), 2017–2024 76
Figure 33: CRC Therapeutics Market, India, Treatment Patterns (‘000), 2017–2024 77
Figure 34: CRC Therapeutics Market, India, Annual Cost of Therapy ($), 2017–2024 78
Figure 35: CRC Therapeutics Market, India, Market Size ($m), 2017–2024 79
Figure 36: CRC Therapeutics Market, China, Treatment Patterns (‘000), 2017–2024 80
Figure 37: CRC Therapeutics Market, China, Annual Cost of Therapy ($), 2017–2024 81
Figure 38: CRC Therapeutics Market, China, Market Size ($bn), 2017–2024 82
Figure 39: CRC Therapeutics Market, Australia, Treatment Patterns (‘000), 2017–2024 83
Figure 40: CRC Therapeutics Market, Australia, Annual Cost of Therapy ($), 2017–2024 84
Figure 41: CRC Therapeutics Market, Australia, Market Size ($m), 2017–2024 85
Figure 42: CRC Therapeutics Market, South Korea, Treatment Patterns (‘000), 2017–2024 86
Figure 43: CRC Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2017–2024 87
Figure 44: CRC Therapeutics Market, South Korea, Market Size ($m), 2017–2024 88
Figure 45: CRC Therapeutics Market, Japan, Treatment Patterns (‘000), 2017–2024 89
Figure 46: CRC Therapeutics Market, Japan, Annual Cost of Therapy ($), 2017–2024 90
Figure 47: CRC Therapeutics Market, Japan, Market Size ($bn), 2017–2024 90
Figure 48: CRC Therapeutics Market, Global, Licensing Deals by Region and Value, 2007–2018 96
Figure 49: CRC Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2007–2018 97
Figure 50: CRC Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 98
Figure 51: CRC Therapeutics Market, Global, Licensing Deals by Molecule Type and Stage of Development, 2007–2018 99
Figure 52: CRC Therapeutics, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2007–2018 100
Figure 53: CRC Therapeutics Market, Global, Co-development Deals by Region and Deal Value, 2007–2018 103
Figure 54: CRC Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2007–2018 104
Figure 55: CRC Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 105
Figure 56: CRC Therapeutics Market, Global, Co-development Deals by Molecule type and Stage of Development, 2007–2018 106
Figure 57: CRC Therapeutics Market, Global, Co-development Deals by Molecular Target, 2007–2018 107